Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45K Buy
374
+80
+27% +$9.24K 0.01% 200
2025
Q4
$30.9K Buy
294
+109
+59% +$10.2K 0.01% 233
2025
Q3
$15.5K Sell
185
-9
-5% -$741 ﹤0.01% 274
2025
Q2
$15.3K Sell
194
-10,009
-98% -$796K ﹤0.01% 263
2025
Q1
$916K Sell
10,203
-416
-4% -$38.8K 0.23% 51
2024
Q4
$1.06M Sell
10,619
-19,740
-65% -$2.04M 0.28% 47
2024
Q3
$3.45M Buy
30,359
+34
+0.1% +$4.04K 0.99% 27
2024
Q2
$3.75M Buy
30,325
+3,146
+12% +$405K 1.15% 24
2024
Q1
$3.59M Buy
27,179
+807
+3% +$99.5K 1.17% 25
2023
Q4
$2.88M Buy
26,372
+210
+0.8% +$21.8K 1.08% 30
2023
Q3
$2.69M Buy
26,162
+752
+3% +$81.1K 1.11% 28
2023
Q2
$2.93M Sell
25,410
-1,894
-7% -$215K 1.19% 26
2023
Q1
$2.9M Buy
27,304
+144
+0.5% +$15.5K 1.2% 27
2022
Q4
$3.01M Buy
27,160
+2
+0% +$204 1.26% 27
2022
Q3
$2.71M Buy
27,158
+8,536
+46% +$762K 1.08% 28
2022
Q2
$1.7M Buy
18,622
+7,239
+64% +$642K 0.66% 42
2022
Q1
$933K Buy
+11,383
New +$897K 0.33% 54

Other funds holding MRK

High Note Wealth's MRK Position: Q1 2026 in Review

High Note Wealth increased its Merck (MRK) stake by 27% in Q1 2026, buying an estimated $9.24K and bringing the position to 374 shares worth $45K. The position accounts for 0.01% of the portfolio, ranked #200.

High Note Wealth first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.75M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • High Note Wealth held 374 shares of Merck worth $45K as of Q1 2026.
  • High Note Wealth bought 80 Merck shares in Q1 2026, an estimated $9.24K.
  • Merck made up 0.01% of High Note Wealth's portfolio in Q1 2026, its #200 holding.
  • High Note Wealth first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • High Note Wealth's Merck position peaked at $3.75M in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.